MESSAGE FROM THE ASSOCIATE DIRECTOR
|
Monica Webb Hooper, PhD Associate Director for Cancer Disparities Research, Case Comprehensive Cancer Center
|
Reflecting on the 3rd Annual Cancer Disparities Symposium
"We should ask ourselves what is one thing we can do from here to make a difference in the community?" - Louis J. Norvak, MD Radiation Oncology Lake Health | University Hospitals Seidman Cancer Center
On March 1, 2019, over 200 people convened in the state-of-the-art Tinkham Veale University Center on the Case Western Reserve University campus for the 3rd Annual Cancer Disparities Symposium "Eliminating Cancer Disparities: Staying the Course Toward Collective Impact." The phrase, "stay the course," used historically in the context of battle, refers to a concentrated effort to persist through obstacles and challenges. This exemplifies what is necessary to achieve the goal of disparity elimination in all domains. In its third year, the Cancer Disparities Symposium served to educate, motivate and inspire those in attendance. We were delighted to welcome researchers, clinicians, health professionals, community outreach teams, patient advocates, trainees and key stakeholders from community-based organizations, local government, private foundations, commercial businesses and other entities - representing seven states. We discussed the current landscape of cancer disparities research across the continuum, from basic, clinical and community sciences. We shared ideas and laid the foundation for new partnerships. The energy and collaborative spirit exhibited throughout the day across the many sectors of our local and national community was transformational.
more>
|
|
de Lima Named Chief, Division of Hematology and Oncology at University Hospitals
The
Case Comprehensive Cancer Center
extends congratulations to Marcos de Lima, MD
for his recent promotion to Chief of Hematology and Oncology at University Hospitals Cleveland Medical Center and Seidman Cancer Center. de Lima is Co-leader of the Case CCC's Hematopoietic and Immune Cancer Biology Program and professor of hematology and oncology at Case Western Reserve University School of Medicine.
"I see leading the Division as a, 'connecting the dots' job - a great opportunity to increase the link between basic and clinical researchers and develop a common language that ultimately benefits our patients all while advancing science," he said. "It will be fun!"
|
Lathia Named Vice Chair, Department of Cardiovascular and Metabolic Sciences at CCLRI
Please join us in congratulating Justin Lathia, PhD for his promotion to Vice Chair
of the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic Lerner Research Institute (CCLRI). "I look forward to working with the institutional and department leadership to continue to build our research programs and fulfill our mission to understand the underlying causes of human diseases and to develop new treatments and cures," said Lathia. He is Co-leader of the Case Comprehensive Cancer Center's Molecular Oncology Program.
|
Rotz Selected as CTSC KL2 Scholar
The Clinical & Translational Science Collaborative (CTSC) recently announced clinical scholars selected
for their KL2 career development program beginning July 2019. Among those selected is Cleveland Clinic pediatric hematologist-oncologist Seth Rotz, MD. Rotz is a member of the Case CCC's Cancer Prevention, Control & Population Research Program.
|
NCI Director Ned Sharpless Appointed Acting FDA Commissioner
National Cancer Institute (NCI) Director Ned
Sharpless, MD will assume the role of acting commissioner of the US Food and Drug Administration
in early April 2019.
Sharpless will succeed resigning commissioner Scott Gottlieb as the administration searches for a permanent replacement.
The NCI's Deputy Director, Douglas Lowy, MD, will then assume the role of acting director of the institution, a role he previously held during the Obama administration. Jim Doroshow, Dinah Singer and Donna Siegle will also make the transition as deputies. In his announcement, he noted he has, "every confidence that the NCI will continue to serve the American public with honor in meeting the formidable challenges that cancer still poses."
|
Cancer Center Seminar Series: "Mitochondrial Fission: Structure, Function and Cancer Implications"
Mar 15, 12p | WRB Auditorium
Join us today at noon in the Wolstein Research
Building Auditorium to hear
Jason Mears, PhD present, "Mitochondrial Fission: Structure, Function and Cancer Implications." Dr. Mears is assistant professor of pharmacology at Case Western Reserve University and a member of the
Case CCC's Molecular Oncology Program. The central goal of his research is to investigate proteins that interact with membranes and alter their
morphologies. His lab has focused on macromolecular complexes that regulate mitochondrial fission and fusion, because these dynamic processes have recently come to the forefront as a therapeutic target in several diseases including neurodegeneration, cancer and aging.
View a list of upcoming seminars>
The Seminar Series
will
be
available to view via live stream. While we highly encourage you to attend in person to interact with our speakers and receive CME credit, we understand that may not always be possible. Presentations will not be recorded for later viewing, but you may watch the seminar in real time and ask questions via chat.
Watch live at noon>
|
Biomedical Innovation & Entrepreneur Club
Mar 20, 4-6p | BRB 932
Case Western Reserve University is home to a
new entrepreneurship club, meeting the third Wednesday of every month! Graduate students, medical students and post-docs are welcome to attend.
Curious to know how the licensing process works for commercializing a product or therapeutic? As a student, what is your share of the intellectual property? Please bring your questions to the next meeting with Stephanie Weidenbecher, MBA, MS and Wayne Hawthorne, MBA from the CWRU Tech Transfer Office.
Please contact
cvmp@case.edu with any questions.
|
Save $10 on GvHD Symposium Registration
April 26, 2019 | Cleveland Airport Marriott
Annual Graft
vs. Host Disease Symposium to take place Friday, April 26 at the Cleveland Airport Marriott. Use code
CANCERCENTER
to save $10 on your registration.
This unique conference, which focuses on cutting edge research and new treatments, consists of two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers.
more>
|
Abstracts Due Today: Great Lakes Breast Cancer Research Symposium
May 2-4, 2019 | Columbus, OH
The
Great Lakes Breast Cancer Research Symposium (GLBCRS) will take place May 2-4, 2019 at the
Grand Event Center in Columbus, OH. This symposium will highlight ongoing basic, translational, clinical and population studies addressing the biological mechanisms, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.
The GLBCRS is made possible through the collaboration of The Ohio State University Comprehensive Cancer Center (The James), the UPMC Hillman Cancer Center affiliated with the University of Pittsburgh Schools of the Health Sciences, the Case Comprehensive Cancer Center at Case Western Reserve University (Case CCC) and the WVU Cancer Institute at West Virginia University
. Register today>
|
University Hospitals Funding Opportunities Deadlines: April 1 & 3, 2019
University Hospitals Seidman Cancer Center has released a request for applications for pilot projects are requested for new cancer-focused research proposals utilizing "big data"/health informatics in cancer research with a focus on population health, health services research, quality and longitudinal outcomes. Applications are due April 1, 2019. View the full RFP>
University Hospitals Case Medical Center Neurological Institute and Seidman Cancer Center is requesting applications for collaborative pilot projects in support of the new Center of Exellence for Translational Neuro-Oncology (CETNO). The RFA supports both research awards and an infrastructure award available to both UH and CWRU-affiliated investigators. Applications are due April 3, 2019. View the full RFP>
|
2019 V Foundation Translational Cancer Research Grant Internal Deadline: April 3, 2019
The Case Comprehensive Cancer Center is able to nominate one investigator for the V Foundation's Translational Cancer Research Grant Program. The V Foundation seeks to support translational research projects within the scope of adult cancer research. Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of fewer than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial. The Translational Research Award is a $600,000 grant paid in three annual installments of $200,000. Indirect costs of up to 10% are permitted.
Projects may be focused in ANY area of adult cancer research.
|
Opportunities for Pilot Projects from VeloSano Bike to Cure Deadline: April 30, 2019
With the generous support from VeloSano Bike to Cure 2018, the Case CCC is providing seed funding for highly innovative and potentially impactful proposals that will generate key data for larger, nationally competitive grants. Projects must be aligned with at least one of the eight Case CCC Research Initiatives (Cancer Genomics, Cancer Immunotherapy, Brain Tumors, AYA cancers, Drug Discovery and Development, Women's Cancers, Community and Cancer Disparities, Computational Diagnostic Informatics) and the Center's Strategic Plan. Collaborative, multi-investigator projects are particularly encouraged and preferred. Learn more>
|
Harrington Scholar-Innovator Grants Deadline: May 3, 2019
The Harrington Scholar-Innovator Award
recognizes physician-scientist innovators throughout the US and Canada, whose research has the
potential to change standard of care.
The Scholar-Innovator
Award provides research and drug
development
support to help bridge the gap between basic discovery and the clinical realm.
Up to 12 Harrington Scholar-Innovator awards are made each year through a competitive selection process.
Each award includes:
- $100,000 guaranteed, opportunity to qualify for up to $700,000
- Drug development expertise and project management support through the Harrington Discovery Institute Innovation Support Center
- Consulting services from highly experienced drug development personnel
- Business and commercialization advice
- Clinical development advice
- Regulatory assistance
- IP review and advice
- Assistance identifying and securing additional financial support based on project needs
Learn more about the awards, policies and application process>
|
Northeast Ohio child is the youngest patient in the world to be diagnosed with an extremely rare and extraordinarily aggressive cancer Fox 8 News - Feb 28, 2019 Chairman of the Cleveland Clinic Pediatric Hematology Oncology and Bone Marrow Transplant Rabi Hanna, MD immediately diagnosed the leukemia. Dr. Hanna is a member of the Case CCC's Hematopoietic and Immune Cancer Biology Program.
NCI program's Research Highlights of 2018 includes manuscript by Anant Madabhushi, MS, PhD NCI EGRP - Mar 1, 2019 The manuscript, titled "Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer," was nominated by other researchers as among the best publications in 2018.
Some Progress But Much More To Be Done To Address Racial Disparities In Cancer ideastream - Mar 1, 2019 Ideastream's Lecia Bushak interviews NIMHD Director Eliseo J. Pérez-Stable, MD and Monica Webb-Hooper, PhD at the 3rd Annual Cancer Disparities Symposium regarding racial disparities in cancer.
Cleveland Clinic describes uphill battle when patients face pancreatic cancer Cleveland 19 News - Mar 7, 2019 Cleveland Clinic medical oncologist Davendra Sohal, MD, MPH explains how pancreatic cancer is a hard disease to detect early. Dr. Sohal is a member of the Case CCC's Developmental Therpeutics Program.
|
NIH BULLETIN - Notices and Funding Opportunities
|
|
|
FOLLOW US
|
Have news or updates to share?
Contact our communications team at
|
EVENTS
|
Fri, Mar 15
Cancer Center Seminar Series
Jason Mears, PhD
Assistant Professor, Pharmacology
Case Western Reserve University
"Mitochondrial Fission: Structure, Function and Cancer Implications"
12p WRB Auditorium
|
Mon, Mar 18
Genomic Medicine Institute Costin Leu, PhD
Lal Lab, Cleveland Clinic
"Design and Execution of the First Polygenic Risk Study in Epilepsy"
12p NE1-205
CWRU SOM Lunch & Lecture
Christopher Leggett, MD [MED '86]
Interventional Cardiologist and Entrepreneur
12p Robbins Building
Cancer Center Research Chalk Talk
Magdalena Grabowska, PhD
Assistant Professor, Urology, Case Western Reserve University
1p WRB 3-136
7th Annual Hopfer Lecture
Alicia A. McDonough, PhD, FAHA
Professor of Integrative Anatomical Sciences
Keck School of Medicine
University of Southern California "Maintaining Balance under Pressure: Renal Adaptations to Angiotensin II Hypertension in Females and Males"
3:30p reception
4p lecture SOM/Robbins Building E-501
|
Tues, Mar 19
CWRU SOM Faculty Toolkit Session
Promotion & Tenure for Faculty in the Tenure Track
12p BRB 105
Cancer Center Drug Discovery and Resistance
George Stark, PhD
Professor Emeritus, Cancer Biology
CWRU/Cleveland Clinic
3p WRB 1-422D
|
Thurs, Mar 21
Developmental Therapeutics Journal Club
9a NE6-218
Molecular Biology and Microbiology Virology Journal Club
RCR+4: Human CRISPR
1p SOM W203
|
Fri, Mar 22
Taussig Cancer Institute Grand Rounds
8a CA5-120
Cancer Center Seminar Series
John DiPersio, MD, PhD
Virginia E and Samuel J Goldman Professor of Medicine
Chief, Division of Oncology Deputy Director
Siteman Cancer Center Washington University School of Medicine
"
Optimizing Allogeneic Transplant for the Treatment of Acute Leukemia
"
12p WRB Auditorium
NCCN Annual Conference
Timothy Gilligan, MD, MS
"Staging of Testicular Cancer: Germ Cell Tumors"
3:25p Orlando, FL
|
Mon, Mar 25
Genomic Medicine Institute Masahiro Hitomi, MD, PhD
"PTEN in Cell Fate Decision; Case of Neural Stem Cell"
12p NE1-205
Cancer Center Research Chalk Talk
Youwei Zhang, PhD
1p WRB 3-136
|
Tues, Mar 26
CWRU SOM Staff Toolkit Session
Benefits
12p BRB 105
Cancer Imaging Monthly Meeting
1:30p WRB 1-422D
|
Thurs, Mar 28
Developmental Therapeutics Journal Club
9a N
E
6-218
Molecular Biology and Microbiology Seminar
Andrew Mack
1p SOM W203
|
Fri, Mar 29
Taussig Cancer Institute Grand Rounds
8a CA5-120
AACR Annual Meeting 2019
Mar 29-April 3
Atlanta, GA
Cancer Center Seminar Series
John T. Schiller, PhD
NIH Distinguished Investigator
Center for Cancer Research
National Cancer Institute
"HPV VLPs: Nature Nanoparticles for Cancer Prevention and Treatment"
12p WRB Auditorium
|
ADDITIONAL UPCOMING SYMPOSIUMS & EVENTS
NCCN Annual Conference
March 21-23, 2019
Orlando, FL
Genomic Medicine Institute International PTEN Symposium
April 8, 2019
Intercontinental Hotel & Conference Center
44th Annual ONS Congress
April 11-14, 2019
Anaheim, CA
Dialogue for Action® on Cancer Screening and Prevention
April 24-26, 2019
Arlington, VA
GvHD National Symposium
Apr 26, 2019
Cleveland Airport Marriott
Apr 27-28, 2019
Seattle, WA
Cancer Center Scientific Series: Research Innovation Fund
May 1, 2019 | 8:30a
WRB Auditorium
2019 Great Lakes Breast Cancer Research Symposium
May 2, 2019
Columbus, OH
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Deadline: Mar 15, 2019
Internal Deadline: Mar 18, 2019
Deadline: Mar 18, 2019
Internal Deadline: Mar 19, 2019
Neuroendocrine Tumor Research Foundation-AACR Grant
Deadline: Mar 19, 2019
Deadlines: Apr 1 & Oct 15, 2019
Foundation for Women's Wellness Research Awards
Deadline: Apr 5, 2019
Deadline: Apr 15, 2019
Deadline: July 24, 2019
Deadline: July 24, 2019
Deadline: July 31, 2019
Deadline: July 31, 2019
Deadline: Open
Case CCC Travel Awards for Trainees
Deadline: Open
Deadline: Open
Deadline: Open
Deadline: Open
Deadline: Open
|
|
|
|